Literature DB >> 17213428

Deep brain reversible encephalopathy: association with secondary antiphospholipid antibody syndrome.

T Parikh1, K Shifteh, M L Lipton, J A Bello, A L Brook.   

Abstract

We present a case of a patient with systemic lupus erythematosus and secondary antiphospholipid syndrome. The patient presented with acute right cerebellar infarction and clinical and imaging evidence of brain stem and bilateral thalamic encephalopathy that resolved completely.

Entities:  

Mesh:

Year:  2007        PMID: 17213428      PMCID: PMC8134088     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  14 in total

1.  Pontine reversible edema: a newly recognized imaging variant of hypertensive encephalopathy?

Authors:  S O Casey; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

Review 2.  The antiphospholipid syndrome.

Authors:  Jerrold S Levine; D Ware Branch; Joyce Rauch
Journal:  N Engl J Med       Date:  2002-03-07       Impact factor: 91.245

Review 3.  Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature.

Authors:  M J Cuadrado; M A Khamashta; A Ballesteros; T Godfrey; M J Simon; G R Hughes
Journal:  Medicine (Baltimore)       Date:  2000-01       Impact factor: 1.889

4.  Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping.

Authors:  K J Ahn; W J You; S L Jeong; J W Lee; B S Kim; J H Lee; D W Yang; Y M Son; S T Hahn
Journal:  Neuroradiology       Date:  2004-11-05       Impact factor: 2.804

Review 5.  The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation.

Authors:  F G I Jennekens; L Kater
Journal:  Rheumatology (Oxford)       Date:  2002-06       Impact factor: 7.580

6.  Risk factors for central nervous system involvement in systemic lupus erythematosus.

Authors:  F B Karassa; J P Ioannidis; G Touloumi; K A Boki; H M Moutsopoulos
Journal:  QJM       Date:  2000-03

Review 7.  Central nervous system involvement in the antiphospholipid (Hughes) syndrome.

Authors:  G Sanna; M L Bertolaccini; M J Cuadrado; M A Khamashta; G R V Hughes
Journal:  Rheumatology (Oxford)       Date:  2003-02       Impact factor: 7.580

8.  Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies.

Authors:  Antonella Afeltra; Pierluigi Garzia; Anna Paola Mitterhofer; Marta Vadacca; Sara Galluzzo; Flavia Del Porto; Licia Finamore; Stefano Pascucci; Marina Gasparini; Bruno Laganà; Domenico Caccavo; Giovanni Maria Ferri; Antonio Amoroso; Ada Francia
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

9.  Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients.

Authors:  J L Vianna; M A Khamashta; J Ordi-Ros; J Font; R Cervera; A Lopez-Soto; C Tolosa; J Franz; A Selva; M Ingelmo
Journal:  Am J Med       Date:  1994-01       Impact factor: 4.965

Review 10.  Brainstem involvement in hypertensive encephalopathy: clinical and radiological findings.

Authors:  Salvador Cruz-Flores; Francisco de Assis Aquino Gondim; Enrique C Leira
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

View more
  3 in total

1.  Hemichorea with antiphospholipid antibodies in a patient with systemic lupus erythematosus.

Authors:  Ana Vide Brochado; Sofia Pimenta; Marta Silva; Raquel Sousa; Maria Manuel Campos; Iva Brito
Journal:  BMJ Case Rep       Date:  2009-08-19

Review 2.  Anti-phospholipid syndrome leading to digital ischaemia and rare organ complications in systemic sclerosis and related disorders.

Authors:  Saion Chatterjee; John D Pauling
Journal:  Clin Rheumatol       Date:  2020-09-21       Impact factor: 2.980

3.  The challenges of antiphospholipid syndrome: experience from diagnosis to self-care.

Authors:  Kathryn Larmour; Gareth Lewis; Gary Benson; Jennifer Hanko
Journal:  BMJ Case Rep       Date:  2014-06-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.